Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent cancer in humans and has the potential to progress locally, metastasize, and cause death in a subset of patients. cSCC is especially common in the elderly, and it will probably represent a major health concern in the near future. S...
Main Authors: | Gloria Baeza-Hernández, Javier Cañueto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/1/158 |
Similar Items
-
A prospective comparative study of efficacy of intralesional bleomycin injection with intralesional 5-FU injection in resistant palmo-plantar warts
by: Prasoon Sachan, et al.
Published: (2023-01-01) -
Successful treatment of squamous cell carcinoma with intralesional methotrexate
by: L.G. Vega-González, MD, et al.
Published: (2022-06-01) -
Efficacy of intralesional aqueous bleomycin in treatment of pediatric lymphatic malformations
by: Suhasini Gazula, et al.
Published: (2022-01-01) -
Intralesional bleomycin versus cryotherapy for treatment of cutaneous warts: a randomized controlled trial
by: Javaria Rahmatullah, et al.
Published: (2023-09-01) -
Intralesional Interstitial Injection of Bleomycin for Management of Extracranial Arteriovenous Malformations in Children
by: Yun ZOU, et al.
Published: (2021-06-01)